Back
Sarepta Therapeutics Stock Price Chart
Trump's "Document 20" Revealed: Smart Americans Could Get Rich During His 2nd Term
See if stocks could soar as much as 1,000% if history repeats itself.
Sell
31
SRPT
Sarepta Therapeutics
Last Price:
109.05
Seasonality Move:
19.2%
7 Day Trial
ALL ACCESS PASS
$
7
"This Changes Everything" - Trump Hands Millions Massive IRS Gift
Learn More Here- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing selling pressure, which indicates risk of future bearish movement.
Sarepta Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 120.33 | Sell |
| 20-day SMA: | 125.09 | Sell |
| 50-day SMA: | 124.91 | Sell |
| 200-day SMA: | 130.53 | Sell |
| 8-day EMA: | 119.07 | Sell |
| 20-day EMA: | 122.65 | Sell |
| 50-day EMA: | 126.04 | Sell |
| 200-day EMA: | 127.3 | Sell |
Sarepta Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -2.6 | Sell |
| Relative Strength Index (14 RSI): | 30.53 | Sell |
| Chaikin Money Flow: | -576241 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (119.6 - 129.58) | Sell |
| Bollinger Bands (100): | (122.9 - 146.68) | Sell |
Sarepta Therapeutics Technical Analysis
| Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Sarepta Therapeutics Stock
Is Sarepta Therapeutics Stock a Buy?
- Sarepta Therapeutics share price is 112.48 while SRPT 8-day simple moving average is 120.33, which is a Sell signal.
- The stock price of SRPT is 112.48 while Sarepta Therapeutics 20-day SMA is 125.09, which makes it a Sell.
- Sarepta Therapeutics 50-day simple moving average is 124.91 while SRPT share price is 112.48, making it a Sell technically.
- SRPT stock price is 112.48 and Sarepta Therapeutics 200-day simple moving average is 130.53, creating a Sell signal.
SRPT Technical Analysis vs Fundamental Analysis
Sell
31
Sarepta Therapeutics (SRPT)
is a Sell
Is Sarepta Therapeutics a Buy or a Sell?
-
Sarepta Therapeutics stock is rated a Sell
The current Sarepta Therapeutics [SRPT] share price is $112.48. The Score for SRPT is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.
Sarepta Therapeutics Stock Info
Market Cap:
10.74B
Price in USD:
112.48
Share Volume:
957.73K
Sarepta Therapeutics 52-Week Range
52-Week High:
173.25
52-Week Low:
78.67
Sell
31
Sarepta Therapeutics (SRPT)
is a Sell
Sarepta Therapeutics Share Price Forecast
-
What is the Sarepta Therapeutics stock price today?
The Sarepta Therapeutics stock price is 112.48 USD today. -
Will SRPT stock go up or go down?
Sarepta Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Sarepta Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Sarepta Therapeutics is overvalued.
Is Sarepta Therapeutics Stock a Buy?
- Sarepta Therapeutics share price is 112.48 while SRPT 8-day exponential moving average is 119.07, which is a Sell signal.
- The stock price of SRPT is 112.48 while Sarepta Therapeutics 20-day EMA is 122.65, which makes it a Sell.
- Sarepta Therapeutics 50-day exponential moving average is 126.04 while SRPT share price is 112.48, making it a Sell technically.
- SRPT stock price is 112.48 and Sarepta Therapeutics 200-day simple moving average is 127.30, creating a Sell signal.
Fundamental Analysis of Sarepta Therapeutics
Is Sarepta Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $2.79 per share, a decrease next quarter of $0.00 per share, an increase this year of $4.84 per share, and an increase next year of $8.55 per share.
Technical Analysis of Sarepta Therapeutics
Should I short Sarepta Therapeutics stock?
- SRPT Moving Average Covergence Divergence (MACD) indicator is -2.6, suggesting Sarepta Therapeutics is a Sell
- Sarepta Therapeutics Relative Strength Index (RSI) is 30.53, which suggest Sarepta Therapeutics is oversold
- The Bollinger Bands (25) for Sarepta Therapeutics is (119.6 - 129.58), which suggest Sarepta Therapeutics is a Sell
- The Bollinger Bands (100) for Sarepta Therapeutics is (122.9 - 146.68), which suggest Sarepta Therapeutics is a Sell
* Sarepta Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.